BATS BZX Real-Time Price
As of 11:10am ET
| -0.06 / -0.85%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +28.94% increase from the last price of 6.98.
The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.